Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital

Journal of the Medical Association of Thailand

Volumn 90, Issue 2, 2007, Pages 258-265

  Tantracheewathorn, Taweewong ^a   Vititpatarapak, Niramon ^a   Phumisantiphong, Uraporn ^a  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

Author keywords

Children; Epidemiologic study; Nosocomial bacterial infection; Susceptibility patterns

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER; ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD FLOW; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; SERRATIA; SKIN; SOFT TISSUE; STAPHYLOCOCCUS AUREUS; URINARY TRACT;

CHILD; CROSS INFECTION; DISEASE SUSCEPTIBILITY; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; POPULATION SURVEILLANCE; RISK FACTORS; THAILAND;

EID: 33847713339     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-601.
3. File TM Jr. Overview of resistance in the 1990s. Chest 1999; 115(Suppl 3): 3S-8S.
4. Thamlikitkul V, Jintanothaitavorn D, Sathitmethakul R, Vaithayaphichet S, Trakulsomboon S, Danchaivijitr S. Bacterial infections in hospitalized patients in Thailand in 1997 and 2000. J Med Assoc Thai 2001; 84: 666-73.
5. Mongkolrattanothai K, Chokephaibulkit K, Kolatat T, Vanprapar N, Chearskul S, Srihapol N, et al. Nosocomial bloodstream infection in pediatric patients: Siriraj Hospital, Bangkok; 1996-1999. J Med Assoc Thai 2001; 84: 160-5.
6. Sader HS, Gales AC, Pfaller MA, Mendes RE, Zoccoli C, Barth A, et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis 2001; 5: 200-14.
7. Hsueh PR, Chen ML, Sun CC, Chen WH, Pan HJ, Yang LS, et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002; 8: 63-8.
8. Chang MR, Carvalho NC, Oliveira AL, Moncada PM, Moraes BA, Asensi MD. Surveillance of pediatric infections in a teaching hospital in Mato Grosso do Sul, Brazil. Braz J Infect Dis 2003; 7: 149-60.
9. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003; 22: 686-91.
10. Kholy AE, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999-2000: a survey of five hospitals. J Antimicrob Chemother 2003; 51: 625-30.
11. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50: 59-69.
12. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. National Nosocomial Infections Surveillance System. Clin Infect Dis 2005; 41: 848-54.
13. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996; 100(Suppl 6A): 3S-12S.
14. National Committee for Clinical Laboratory Standards. Performance for antimicrobial susceptibility testing. 9th information supplement. Document M100-S9. Wayne, PA: NCCLS; 1999.
15. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323: 301-8.
16. Sidebottom DG, Freeman J, Platt R, Epstein MF, Goldmann DA. Fifteen-year experience with bloodstream isolates of coagulase-negative Staphylococci in neonatal intensive care. J Clin Microbiol 1988; 26: 713-8.
17. Karlowicz MG, Furigay PJ, Croitoru DP, Buescher ES. Central venous catheter removal versus in situ treatment in neonates with coagulase-negative staphylococcal bacteremia. Pediatr Infect Dis J 2002; 21: 22-7.
18. Denis O, Nonhoff C, Byl B, Knoop C, Bobin-Dubreux S, Struelens MJ. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J Antimicrob Chemother 2002; 50: 383-91.
19. Phongsamart W, Srifeungfung S, Tiensasitorn C, Vanprapar N, Chearskul S, Chokephaibulkit K. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand. J Med Assoc Thai 2005; 88(Suppl 8): S264-S268.
20. Center for Diseases Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565-7.
21. Tonkic M, Goic-Barisic I, Punda-Polic V. Prevalence and antimicrobial resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 2005; 8: 119-24.
22. Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol 2000; 38: 3299-305.
23. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 2005; 43: 4826-9.
24. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 1994; 330: 1247-51.